Related Experiment Video
Updated: Jan 12, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression
Yating Du1, Jingjing Wang1, Min Wang1
1Collaborative Innovation Center of Cell Biology in Universities of Shandong, Center for Cell Structure and Function, College of Life Sciences, Modern Industry Institute of Biomedicine, Shandong Normal University, Jinan, 250014, China.
Abstract:
Nucleolar and spindle-associated protein 1 (NUSAP1) is critical for cancer progression. However, its function in cancers is context-dependent, and emerging evidence indicates that NUSAP1 possesses tumor suppressor functions, although the underlying mechanisms remain uncharted. In this study, NUSAP1 depletion is found to significantly increases the proliferation, migration, and invasion of triple-negative breast cancer (TNBC) cells in vitro and promotes TNBC progression in vivo, suggesting that NUSAP1 is a tumor suppressor in TNBC. Mechanistically, NUSAP1 bridges HIFα and the transcriptional repressor death domain-associated protein (DAXX) through its microtubule-associated domain (MAD) to recruit the methyltransferase SETDB1, thereby attenuating HIF transcriptional activity and the expression of its target genes by depositing the H3K9me3 repressive mark on hypoxia response elements (HREs). Intriguingly, an engineered MAD of NUSAP1, designated as Tumor Suppressor-MAD (TS-MAD), is developed, which effectively abrogates HIF transcriptional activity by bridging the DAXX-HIF interaction, consequently inhibiting HIF-driven TNBC progression. Moreover, NUSAP1 is identified as a novel HIF-repressed gene in TNBC cells, and its expression level shows a negative correlation with clinical outcomes in TNBC patients. These findings establish an HIF-NUSAP1 double-negative feedback loop in TNBC and validate TS-MAD as a potential therapeutic strategy for HIF-driven cancer.
Insights
Nucleolar and spindle-associated protein 1 (NUSAP1) acts as a tumor suppressor in triple-negative breast cancer (TNBC). NUSAP1 inhibits cancer progression by attenuating HIF transcriptional activity, and a modified NUSAP1 domain shows therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Nucleolar and spindle-associated protein 1 (NUSAP1) plays a context-dependent role in cancer.
- Emerging evidence suggests NUSAP1 may function as a tumor suppressor, but the mechanisms are unclear.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
Purpose of the Study:
- To investigate the role of NUSAP1 in TNBC progression.
- To elucidate the molecular mechanisms by which NUSAP1 suppresses TNBC.
- To explore the therapeutic potential of targeting the NUSAP1 pathway in TNBC.
Main Methods:
- NUSAP1 depletion in TNBC cells in vitro and in vivo.
- Co-immunoprecipitation to study protein interactions (NUSAP1, HIFα, DAXX, SETDB1).
- Chromatin immunoprecipitation to assess H3K9me3 deposition.
- Development and testing of an engineered NUSAP1 microtubule-associated domain (TS-MAD).
Main Results:
- NUSAP1 depletion enhanced TNBC cell proliferation, migration, and invasion, and promoted tumor growth in vivo.
- NUSAP1 bridges HIFα and DAXX, recruiting SETDB1 to deposit H3K9me3 on hypoxia response elements (HREs), thus suppressing HIF transcriptional activity.
- An engineered NUSAP1 domain (TS-MAD) inhibited HIF transcriptional activity and HIF-driven TNBC progression.
- NUSAP1 is a hypoxia-inducible factor (HIF)-repressed gene in TNBC, and its low expression correlates with poor clinical outcomes.
Conclusions:
- NUSAP1 functions as a tumor suppressor in TNBC by attenuating HIF transcriptional activity.
- A novel HIF-NUSAP1 double-negative feedback loop exists in TNBC.
- The engineered TS-MAD domain represents a potential therapeutic strategy for HIF-driven cancers like TNBC.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

